+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 1Year - 18Years
All Genders
ID05717699

Phase 1 Study of Intratumoral Ad-TD-nsIL12 Virus Injection for Treating Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Led by Capital Medical University · Updated on 2024-02-28

18

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and side effects of a new oncolytic virus called Ad-TD-nsIL12 given as an injection directly into tumors in children aged 1 to 18 with progressive diffuse intrinsic pontine glioma DIPG, a serious brain tumor. This early-phase trial uses a dose-escalation method to carefully observe how patients respond to the virus treatment. The study is led by Capital Medical University and focuses on progressive pediatric DIPG confirmed by biopsy and MRI scans. Participants receive multiple injections of Ad-TD-nsIL12 through an Ommaya reservoir inserted during a stereotactic biopsy. Two initial injections are given three days apart after surgery, followed by additional injections every three weeks, with some flexibility in timing. Doses vary by patient group and range from 3x109 to 3x1010 viral particles suspended in 1 ml of normal saline. The treatment is delivered directly into the tumor site to assess local effects and safety. During the study, patients will be closely monitored with MRI scans to confirm tumor progression and biopsies to verify diagnosis. Safety and side effects will be tracked for three months after the virus injections. Additional assessments include tumor response at three months, overall survival at 12 months, quality of life up to two years, and collection of samples for further study. The total duration of observation extends up to two years to evaluate long-term outcomes and safety.

CONDITIONS

Brief Title

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Research Team

X

Xiao Qian, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here